EP 4 : A new piece in the fibrotic puzzle

Kidney International

Volumn 82, Issue 2, 2012, Pages 132-135

  Boor, Peter ^a,b  

^a RWTH AACHEN UNIVERSITY   (Germany)

^b Faculty of Natural Sciences   (Slovakia)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; CONNECTIVE TISSUE GROWTH FACTOR; CREATININE; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; G PROTEIN COUPLED RECEPTOR; HYDROXYPROLINE; MONOCYTE CHEMOTACTIC PROTEIN 1; PROSTAGLANDIN E RECEPTOR 1; PROSTAGLANDIN E RECEPTOR 2; PROSTAGLANDIN E RECEPTOR 4; PROSTAGLANDIN E RECEPTOR 4 STIMULATING AGENT; PROSTAGLANDIN E SYNTHASE; PROSTAGLANDIN RECEPTOR STIMULATING AGENT; RANTES; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG; PROSTAGLANDIN E2; PTGER4 PROTEIN, MOUSE;

ACUTE KIDNEY FAILURE; CREATININE BLOOD LEVEL; DISEASE COURSE; DOWN REGULATION; ENZYME REGULATION; HUMAN; INFLAMMATORY INFILTRATE; KIDNEY FIBROSIS; KIDNEY FUNCTION; MYOFIBROBLAST; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN SYNTHESIS; REVIEW; SIGNAL TRANSDUCTION; UPREGULATION; URETER OBSTRUCTION; ANIMAL; EPITHELIUM CELL; KIDNEY DISEASE; KIDNEY TUBULE; METABOLISM; NOTE;

ANIMALS; DINOPROSTONE; EPITHELIAL CELLS; KIDNEY DISEASES; KIDNEY TUBULES; RECEPTORS, PROSTAGLANDIN E, EP4 SUBTYPE;

EID: 84863312433     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2012.125     Document Type: Note

References (10)

1. Boor P, Ostendorf T, Floege J. Renal fibrosis: novel insights into mechanisms and therapeutic targets. Nat Rev Nephrol 2010; 6: 643-656.
2. Nakagawa N, Yuhki K-i, Kawabe J-i et al. The intrinsic prostaglandin E 2-EP 4 system of the renal tubular epithelium limits the development of tubulointerstitial fibrosis in mice. Kidney Int 2012; 82: 158-171.
3. Narumiya S, Sugimoto Y, Ushikubi F. Prostanoid receptors: structures, properties, and functions. Physiol Rev 1999; 79: 1193-1226.
4. Okegawa T, Jonas PE, DeSchryver K et al. Metabolic and cellular alterations underlying the exaggerated renal prostaglandin and thromboxane synthesis in ureter obstruction in rabbits. Inflammatory response involving fibroblasts and mononuclear cells. J Clin Invest 1983; 71: 81-90.
5. Whinnery MA, Shaw JO, Beck N. Thromboxane B2 and prostaglandin E2 in the rat kidney with unilateral ureteral obstruction. A m J Physiol 1982; 242: F220-F225.
6. Vukicevic S, Simic P, Borovecki F et al. Role of EP2 and EP4 receptor-selective agonists of prostaglandin E 2 in acute and chronic kidney failure. K idney Int 2006; 70: 1099-1106.
7. Huang SK, White ES, Wettlaufer SH et al. Prostaglandin E 2 induces fibroblast apoptosis by modulating multiple survival pathways. F ASEB J 2009; 23: 4317-4326.
8. Yamamoto E, Izawa T, Juniantito V et al. Involvement of endogenous prostaglandin E2 in tubular epithelial regeneration through inhibition of apoptosis and epithelialmesenchymal transition in cisplatin-induced rat renal lesions. H istol Histopathol 2010; 25: 995-1007 .
9. Stitt-Cavanagh EM, Faour WH, Takami K et al. A maladaptive role for EP4 receptors in podocytes. J Am Soc Nephrol 2010; 21: 1678-1690.
10. Wu J, Zhang Y, Frilot N et al. Prostaglandin E2 regulates renal cell carcinoma invasion through the EP4 receptor-Rap GTPase signal transduction pathway. J Biol Chem 2011; 286: 33954-33962.